Target intelligence / Profile preview

Venous endothelial cell lipid membrane

Molecular classification
Lipid bilayer, Cellular membrane
01

Overview

The venous endothelial cell lipid membrane is the semi-permeable phospholipid bilayer that forms the innermost lining of the venous system. It plays a critical role in maintaining vascular homeostasis, regulating leukocyte adhesion, and acting as a barrier to fluid and solute exchange (PubMed, 11566018). In clinical practice, this membrane is the primary therapeutic target for sclerosant medications used to treat varicose veins and vascular malformations. Sclerosants like polidocanol and sodium tetradecyl sulfate act as detergents that solubilize the lipids and proteins within the membrane, causing immediate cell lysis and denudation of the vessel wall (StatPearls, NBK534213). This targeted destruction initiates a localized thrombotic and fibrotic process that results in the permanent occlusion and eventual resorption of the diseased vein (PubMed, 22455564). The efficacy of these treatments depends on the concentration of the drug and the duration of contact with the endothelial surface. Damage to this membrane, whether intentional or pathological, triggers a cascade of inflammatory signaling and platelet activation.

Other names
Endothelial cell membraneVenous endotheliumVascular endothelial lipid bilayerEndothelial surface
02

Mechanism of action

Detergent-mediated solubilization of membrane lipids and proteins, osmotic dehydration of endothelial cells, and chemical irritation leading to endothelial destruction, localized thrombosis, and vessel fibrosis (StatPearls, NBK534213; PubMed, 22455564).

03

Biological functions

Barrier functionVascular homeostasisSignal transductionCoagulation regulationLeukocyte trafficking
04

Disease associations

Varicose veinsChronic venous insufficiencyVascular malformationsHemorrhoidsTelangiectasia
05

Safety considerations

Tissue necrosis due to extravasationDeep vein thrombosis (DVT)Pulmonary embolismPost-sclerotherapy hyperpigmentationAnaphylaxis (StatPearls, NBK534213)Telangiectatic matting
06

Interacting drugs

Polidocanol

4 more in the full profile.

07

Biomarkers

Clinical vessel disappearanceDuplex ultrasound-confirmed occlusionvon Willebrand factor (vWF) releaseEndothelin-1 levels

Beyond the preview

Go deeper on Venous endothelial cell lipid membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venous endothelial cell lipid membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call